Brief: Maravai Lifesciences Announces Updated CEO Leadership Transition Plans
Dec 1 (Reuters) - Maravai LifeSciences Holdings Inc
MRVI.O :
* MARAVAI LIFESCIENCES ANNOUNCES UPDATED CEO LEADERSHIP
TRANSITION
PLANS
* CARL HULL TO CONTINUE TO SERVE AS EXECUTIVE CHAIRMAN AND
INTERIM
CEO
* WILLIAM MARTIN TO ASSUME ROLE OF MARAVAI'S CEO IN JULY
2023
Source text for Eikon: ID:nGNXbXWmmr
Further company coverage: MRVI.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million